The Pursuit of Exact Truths

Frederick Novy helped lay the groundwork for modern medical science as we know it

Author | Lara Zielin

Photos by Leisa Thompson Photography. Slides and archival images from the Bentley Historical Library.

If you had seen Frederick Novy at the University of Michigan between 1888 and 1933, you might have dismissed him as an eccentric scientist in a threadbare suit and mismatched coat, careening across campus on his bicycle, oblivious to much except the thoughts in his head. You could have even shrugged at the way he holed up in his dim and cramped lab until late at night, poring over data and experiments, almost to obsession. 

But to do so would be to miss his extraordinary contributions to medical science and the U-M Medical School at a time when medicine was lacking certainty and authority. As a student, Novy questioned treatments he was taught, such as bloodletting, cupping and the application of leeches. In his student notebooks and lecture notes, now archived at U-M's Bentley Historical Library, he observed that there were no laboratory exercises to teach students how to investigate the cause of disease. To him, adding laboratory science would "lead to the uplifting of medical education that was needed." 

Through the emerging field of bacteriology, Novy would change the fundamental way medicine was taught, demanding students test and prove. He became the leader of a new breed of physician: academic researchers who did not practice medicine. He would engineer new lab equipment to better see organisms on a cellular level, at a time when some of his U-M colleagues didn't even believe in germ theory. And although he would tout the importance of scientific experiment for its own sake, without worrying about pragmatic application, his work would have profound effects on a deeper understanding of how germs and bacteria behave, leading to reduced incidents of dysentery, cholera, tuberculosis and more. 

A Foundation for a Career 

Novy was born in Chicago in 1864 to parents who had emigrated from Bohemia (now part of the Czech Republic). He was interested in science from an early age, setting up his own chemistry lab under the back steps of the multi-unit dwelling where his family lived. After blowing the steps up by accident, his father moved his experiments to the backyard woodshed. 

Novy entered U-M in 1882, studying chemistry as an undergraduate. He graduated in 1886, received an M.S. in 1887, an Sc.D. of physiological chemistry in 1890 and an M.D. in 1891. A forward-thinking physician named Victor Vaughan, M.S., Sc.D., M.D. (who later became dean of the Medical School) spied Novy's potential and appointed him assistant in the new hygienic laboratory, which Vaughan founded in 1887. The lab performed bacteriological analyses on water, milk and other substances while also carrying out independent research. Together, Vaughan and Novy worked to advance the study of bacteriology at U-M. 

In the summer of 1888, the pair traveled abroad, training in the laboratories of Robert Koch in Berlin. When they returned to Michigan, Novy delved into the study of microbes and germs not to cure disease, but for fundamental, "pure" scientific understanding. 

It was a dramatic shift. Previously, public health departments had viewed disease as something to be stopped — by administering vaccines, reducing rat populations, testing drinking water and other hands-on measures. Now, Novy and Vaughan had equipped a university with a lab for research, working tirelessly to understand germs fundamentally and how they lived in nature. 

Not everyone agreed with this approach. Heneage Gibbes, M.B., a professor of pathology who did not believe in germ theory, was fundamentally opposed to Novy's course dedicated to bacteriology, which Novy launched in the fall of 1889. Along with H.L. Obetz, M.D., dean of the Homeopathic School, Gibbes petitioned the U-M Board of Regents to eliminate Novy's teaching position. With the backing of Vaughan and the ability to reproduce lab results with rigorous methodology, Novy triumphed, and Gibbes left U-M within a year. 

By 1890, Novy's bacteriology course was required for all students. 

The Plague 

Novy's growing reputation and expertise led federal officials to ask him to serve on an independent commission to gauge whether the plague was present in San Francisco in 1901. Novy agreed, thinking this could be an opportunity to take his laboratory investigations to the site of an outbreak. He departed for San Francisco on Jan. 24 , 1901. 

The situation in the city, however, was fraught with politics. Harry Gage, the governor of California, denied the claims, likely to alleviate panic and keep trade flowing. Added to this were racial and cultural stereotypes linking the plague to the city's Chinese residents, who were thought to carry the disease due to hereditary factors. "The press and the people are unanimously against the idea that plague exists here," Novy wrote to his wife, Grace, in letters archived at the Bentley. 

In spite of Novy's ability to isolate Bacillus pestis — demonstrating proof that plague was indeed in San Francisco — it wasn't spreading as rapidly or causing social disruption, and Novy was unable to explain why. Nevertheless, in late February, he and the other commissioners finalized their fact-finding report. Initially, Gov. Gage suppressed the report, but the surgeon general published the findings a couple of months later. Reluctantly, the governor authorized funds for anti-plague measures, including sanitation and disinfection. 

It wasn't until 1903, however, when incidents of the plague were on the uptick and the city was threatened with a trade embargo, that robust rat control and sanitation measures were put in place by a new governor who also was a former physician. 

A Legacy of Scientific Techniques 

Back at U-M, Novy continued to introduce medical students to the latest scientific techniques. He helped students become familiar with preparing and staining specimens, plating and incubating bacteria, inoculating lab animals and more. He stressed technical proficiency and the scientific method. 

Many students responded to the rigor and methodology. "If greatness be measured in terms of medical teaching, Novy was the greatest we ever had," former student David Sugar, M.D., wrote about Novy in the Detroit Medical News

Those students were right to be grateful to Novy, not just for the precision he instilled in them but also because he was changing an entire scientific field while he taught them, says Powel Kazanjian, M.D., Ph.D., professor of internal medicine and chief of the Division of Infectious Diseases, and professor of history in the College of Literature, Science and the Arts. Kazanjian wrote Frederick Novy and the Development of Bacteriology in Medicine, which explores Novy's impact on medicine and society in America. 

For Kazanjian, Novy's story is one that flies too far under the radar. "The textbooks now don't say much about him, partly because of the narrative," Kazanjian says. "With Pasteur and Koch, you have this great narrative of eradicating killer diseases. But with Novy, there's a lot of research and exacting work. It's meticulous, arduous methodology." 

Novy retired from the lab in 1933 but stayed active in the field. He published his last scientific article in 1953 when he was nearly 90 years old. He died in 1957, but his impact on research, and the Medical School, is still felt today. 

"Before Novy, medicine was an experiential profession with a focus on healing," Kazanjian says. "Novy was among the first generation of full-time researcher-educators who came along and introduced a new focus — the search for exact truths in the laboratory." 


Seeing Science

An overhead image of a canoe livery and a previously unknown Kandinsky painting? Not quite. These are slides that were used in Frederick Novy's bacteriology course, showing a parasite in the genus Trypanosoma (left) and the bacteria Spirillum equi (right). Novy was tireless in his work to observe organisms, taking pictures through his microscope and transferring them onto slides. He'd then jot notes in the margins of slides. 



The Frederick G. Novy Papers, Bentley Historical Library. The collection also contains his notebooks, letters, lab notes, photos and more. 

Frederick Novy and the Development of Bacteriology in Medicine, by Powel Kazanjian, M.D., Ph.D. (Rutgers Press, 2017). 

"Frederick George Novy, Microbiologist 1864–1957," by S.E. Gould. American Journal of Clinical Pathology, vol. 29, no. 4, April 1958. 

More Articles About: Frederick Novy Bentley Historical Library archives Research Bicentennial Medical School bacteriology public health MM History
Featured News & Stories Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Vision Impairment as a Risk Factor for Dementia
The population of older adults living with dementia is expected to swell to nearly 14 million by 2050 and is estimated to cost the US economy more than 500 billion each year. In the absence of a cure for Alzheimer's disease, the primary cause of dementia, there's interest in understanding modifiable risk factors. In theory, getting a handle on the modifiable risk factors for dementia, would enable public health efforts to reduce cognitive decline in dementia at the population level. We've come a long way in understanding the risk factors for Alzheimer's disease and other related dementias. However, there's still work to be done. In this episode, we'll speak with Dr. Josh Ehrlich, a researcher at the University of Michigan, who has examined vision impairment as a risk factor for dementia.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Dementia as a Global Challenge – the International Partners Study of the HRS
According to an estimate published in 2015, the global prevalence of dementia was projected to nearly triple between 2015 and 2050, growing from 46 million to over 130 million people globally. And of that worldwide share, 70% of those with dementia will be in low- and middle-income countries. Tackling and ideally preventing dementia requires a global perspective. In this episode, Matt & Donovan speak with Dr. Lindsay Kobayashi, a faculty member in the Department of Epidemiology at the University of Michigan School of Public Health whose research focuses on the social epidemiology of aging from a global perspective. Dr. Kobayashi introduces us to a whole new world of data available to help researchers tackle dementia as a global challenge.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Dementia at the End of Life
Over thirty percent of individuals living with dementia living in the US each year die either of or with dementia – and almost half of those enrolled in hospice have dementia. As with so many other types of healthcare, there are disparities in both who enrolls in hospice as well as the type of care these individuals receive after enrollment. In this episode, Matt & Donovan talk with Dr. Lauren Hunt from UCSF, an expert in hospice care for persons living with dementia, about dementia at the end of life.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Spreading Access to STI Healthcare for Partners
A study explores how to better provide resources to sexual partners of those with STIs. Visit Health Lab to read the full story
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
The Long-Term Care Data Cooperative: Your One Stop Shop for Nursing Home Data
In this episode, Donovan & Matt talk with health services researcher Betsy White from Brown University about a unique new resource for researchers called the Long-Term Data Cooperative, a provider-led data sharing collaboratory that puts together nursing home EHR data from EHR vendors that can be linked to Medicare claims. This powerful tool is made available to researchers through an online application process.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Could Prostate Cancer Drugs Help Fight COVID Infections?
Researchers look into a drug called proxalutamide as a potential therapeutic for the coronavirus.